May 19, 2016

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Colorectal Cancer

May 19, 2016

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Non-Small Cell Lung Cancer

May 6, 2016

Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders

May 6, 2016

Oncolytics Biotech® Inc. Announces 2016 First Quarter Results

May 5, 2016

Oncolytics Biotech® Inc. Announces Presentation of REOLYSIN® Preclinical Research at the 2016 ASGCT Annual Meeting

May 3, 2016

Oncolytics Biotech® Inc. Announces Details of 2016 Annual Meeting of Shareholders

Apr 29, 2016

Oncolytics Biotech® Inc. to Participate in the Bloom Burton & Co. Healthcare Investor Conference

Apr 29, 2016

Oncolytics Biotech® Inc. Announces Formation of Science and Technology Committee

Apr 18, 2016

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Research at the 2016 AACR Annual Meeting

Apr 14, 2016

Oncolytics Biotech® Inc. Reports Updated Data from Randomized Phase 2 Study of REOLYSIN® in Pancreatic Cancer